Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Amphotericin B (AMB) is an effective antifungal agent. However, its therapeutic use is hampered by its toxicity, mainly due to channel formation across kidney cell membranes and the disruption of postendocytic trafficking. We previously described a safe injectable AMB-arabinogalactan (AG) conjugate with neutralized toxicity. Here we studied the mechanism of the toxicity of free AMB and its neutralization by conjugation with AG. AMB treatment of a kidney cell line modulated the trafficking of three receptors (C-X-C chemokine receptor type 4 [CXCR4], M1 receptor, and human transferrin receptor [hTfnR]) due to an increase in endosomal pH. Similar data were also obtained in yeast but with an increase in vacuolar pH and the perturbation of Hxt2-green fluorescent protein (GFP) trafficking. The conjugation of AMB with AG neutralized all elements of the toxic activity of AMB in mammalian but not in fungal cells. Based on these results, we provide an explanation of how the conjugation of AMB with AG neutralizes its toxicity in mammalian cells and add to the knowledge of the mechanism of action of free AMB in both fungal and mammalian cells.

Citation

Sarah Kagan, Diana Ickowicz, Miriam Shmuel, Yoram Altschuler, Edward Sionov, Miriam Pitusi, Aryeh Weiss, Shimon Farber, Abraham J Domb, Itzhack Polacheck. Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan. Antimicrobial agents and chemotherapy. 2012 Nov;56(11):5603-11

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22908154

View Full Text